BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 34134006)

  • 1. Combination of albumin-globulin score and skeletal muscle index predicts long-term outcomes of intrahepatic cholangiocarcinoma patients after curative resection.
    Li H; Dai J; Lan T; Liu H; Wang J; Cai B; Xu L; Yuan K; Wang G; Wu H
    Clin Nutr; 2021 Jun; 40(6):3891-3900. PubMed ID: 34134006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of sarcopenia on the short-term and long-term outcomes of intrahepatic cholangiocarcinoma undergoing hepatectomy: A multi-center study.
    Li R; Chen B; Chen Z; Su Q; He Q; Yang J; Xu P; Hu J; Jin Y; Bo Z
    Eur J Surg Oncol; 2024 Apr; 50(4):108246. PubMed ID: 38484491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of sarcopenia on postoperative outcomes after hepatectomy in older patients with intrahepatic cholangiocarcinoma: A multicentre cohort study.
    Zhao Z; Bo Z; Ye N; Dong Y; Xu Y; Wang B; Yang F; Liu L; Liu Z
    Liver Int; 2024 Jan; 44(1):155-168. PubMed ID: 37804070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor burden score and carcinoembryonic antigen predict outcomes in patients with intrahepatic cholangiocarcinoma following liver resection: a multi‑institutional analysis.
    Fu J; Zheng L; Tang S; Lin K; Zheng S; Bi X; Wang J; Guo W; Li F; Wang J; Wang K; Li H; Zeng Y
    BMC Cancer; 2024 Mar; 24(1):358. PubMed ID: 38509498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathology-based immunoscore predicts recurrence for intrahepatic cholangiocarcinoma after hepatectomy.
    Tian MX; Zhou YF; Qu WF; Liu WR; Jin L; Jiang XF; Wang H; Tao CY; Zhou PY; Fang Y; Ding ZB; Peng YF; Zhou J; Fan J; Shi YH
    Cancer Immunol Immunother; 2019 Aug; 68(8):1369-1378. PubMed ID: 31338558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Sarcopenia on the Prognosis of Clinical Outcomes in Patients With Hepatocellular Carcinoma After Hepatic Resection.
    Polvieng T; Hongjinda S; Thienhiran A; Burasakarn P; Fuengfoo P
    Am Surg; 2024 Mar; ():31348241241713. PubMed ID: 38516765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skeletal Muscle Mass Index Reduction Rate as a Prognostic Indicator for Patients Undergoing Pancreatectomy for Pancreatic Cancer.
    Mita J; Maeda T; Tsujita E; Hashimoto N; Fujikawa R; Ono Y; Sakai A; Tanaka S; Matono R; Ohmine T; Kometani T; Yamaguchi S; Konishi K; Hashimoto K
    Cancer Diagn Progn; 2024; 4(3):301-308. PubMed ID: 38707741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive Value of a New Muscle Parameter in Patients with Resectable Gastric Cancer: A Pooled Analysis of Three Prospective Trials.
    Zhong Q; Huang JB; Lu J; Xue LW; Lin GT; Xie JW; Lin JX; Zheng CH; Huang CM; Li P
    Ann Surg Oncol; 2024 May; 31(5):3005-3016. PubMed ID: 38270825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and predictive value of sarcopenia in surgically treated cholangiocarcinoma: a comprehensive review and meta-analysis.
    He J; Huang Y; Huang N; Jiang J
    Front Oncol; 2024; 14():1363843. PubMed ID: 38571501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histological classification of microvascular invasion to predict prognosis in intrahepatic cholangiocarcinoma.
    Shao C; Chen J; Chen J; Shi J; Huang L; Qiu Y
    Int J Clin Exp Pathol; 2017; 10(7):7674-7681. PubMed ID: 31966613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The coexistence of myosteatosis and the creatinine/cystatin C ratio are determinants of outcomes in cholangiocarcinoma patients undergoing curative surgery.
    Liu Y; Zhang J; Song G; Ding X; Sun H; Zhou J; Jing X
    Front Oncol; 2024; 14():1233768. PubMed ID: 38706605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of skeletal muscle mass on postoperative complications in oral cancer surgery.
    Fujii A; Suzuki T; Sakai K; Matsuura N; Sugahara K; Katakura A; Nomura T
    Maxillofac Plast Reconstr Surg; 2024 Mar; 46(1):12. PubMed ID: 38538802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Nomogram Based on Hepatic and Coagulation Function for Evaluating Outcomes of Intrahepatic Cholangiocarcinoma After Curative Hepatectomy: A Multi-Center Study of 653 Patients.
    Cai Y; Zhang B; Li J; Li H; Liu H; Xie K; Du C; Wu H
    Front Oncol; 2021; 11():711061. PubMed ID: 34322394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-6-induced cGGNBP2 encodes a protein to promote cell growth and metastasis in intrahepatic cholangiocarcinoma.
    Li H; Lan T; Liu H; Liu C; Dai J; Xu L; Cai Y; Hou G; Xie K; Liao M; Li J; Huang J; Yuan K; Wang G; Zeng Y; Wu H
    Hepatology; 2022 Jun; 75(6):1402-1419. PubMed ID: 34758510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative damage effect of jaundice may be an effective predictor of complications in patients undergoing radical resection of Bismuth type II or above hilar cholangiocarcinoma.
    Luo L; Yao Y; Liao H; Huang J; Liao M; Wang J; Yuan K; Zeng Y
    Ann Transl Med; 2021 May; 9(10):861. PubMed ID: 34164495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Combined CA19-9 with Aspartate Aminotransferase to Lymphocyte Ratio in Patients with Intrahepatic Cholangiocarcinoma After Hepatectomy.
    Qiu H; Liu C; Huang M; Shen S; Wang W
    Cancer Manag Res; 2021; 13():5969-5980. PubMed ID: 34377017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen/albumin ratio index is an independent predictor of recurrence-free survival in patients with intrahepatic cholangiocarcinoma following surgical resection.
    Liu H; Qiu G; Hu F; Wu H
    World J Surg Oncol; 2021 Jul; 19(1):218. PubMed ID: 34284775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography.
    Mitsiopoulos N; Baumgartner RN; Heymsfield SB; Lyons W; Gallagher D; Ross R
    J Appl Physiol (1985); 1998 Jul; 85(1):115-22. PubMed ID: 9655763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A possible combined appraisal pattern: predicting the prognosis of patients after esophagectomy.
    Chen L; Yu G; Zhao W; Ye B; Shu Y
    World J Surg Oncol; 2023 May; 21(1):155. PubMed ID: 37211596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of sarcopenia-based nomograms predicting postoperative complications of benign liver diseases undergoing hepatectomy: A multicenter cohort study.
    Bo Z; Chen Z; Chen B; Yang J; Zhao Z; Yang Y; Ma J; He Q; Yu H; Zheng C; Chen K; Wang Y; Chen G
    Front Nutr; 2023; 10():1040297. PubMed ID: 36845061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.